US Patent Family Members and Approved Drugs for Japan Patent: 4250660
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Japan Patent: JP4250660
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| ⤷ Get Started Free | 2020-12-21 | ocriplasmin | Thrombogenics Inc. | JETREA |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
